Recruiting PHASE2 INTERVENTIONAL 2-arm NCT05004610

Hypertonic Lactate After Cardiac Arrest (LATTE)

Sponsor: Erasme University Hospital

Conditions Anoxic Brain Injury Cardiac Arrest Ischemia Reperfusion Injury

Updated 6 times since 2021 Last updated: Feb 20, 2025 Started: Feb 19, 2025 Primary completion: Dec 31, 2027 Completion: May 15, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Anoxic Brain Injury and Cardiac Arrest, this trial is actively recruiting participants. The trial is conducted by Erasme University Hospital and has accumulated 6 data snapshots since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Mar 2025 — Present [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Jan 2025 — Mar 2025 [monthly]

Not Yet Recruiting PHASE2
Sep 2024 — Jan 2025 [monthly]

Not Yet Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE2
Mar 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE2

▶ Show 1 earlier version

Sep 2021 — Mar 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erasme University Hospital

Data source: Erasme University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium